New Generation of Topical Pain Cream
The Topical A formulation provides a new generation of relief from chronic pain by exploiting the CB2 receptor of the endocannabinoid system, which is the body’s built in pain and inflammation defense system. Topical AOTC (over the counter) is a unique Health Canada approved topical cream that provides relief from pain through complimentary mechanisms of action not found in any other product currently available on the market.
What separates Topical AOTC from other topical analgesic products currently available on the market is Topical AOTC‘s unique dual action formula that specifically targets the body’s endocannabinoid system.
The first agent in Topical A activates the CB2 receptors and so is able to assist with decreasing pain but without causing a high or affecting mental functions often associated with other pain killers.
In fact, this agent does not come from cannabis.
The second agent is capsaicin which activates another receptor involved in pain transmission.
This combination is able to fight pain in 2 ways. This novel formulation has never been utilized before.
Topical AOTC is currently undergoing limited trials and is only available to consumers through a small number of pain clinics and physicians across Canada.
If you are currently using Topical AOTC and would like to know more information about product usage and dosage, please read our Topical AOTC monograph or find answers to common questions in our FAQ.